The nominal group technique (NGT) allows stakeholders to Background: directly generate items for needs assessment. The objective was to demonstrate the use of NGT to inform the development of a healthcare app in patients with relapsed myeloma. Healthcare professionals with experience in the care of patients with relapsed/refractory myeloma were invited to participate.
Introduction
Patient participation and engagement in research for the development of health research priorities has increased in importance more recently. The Irish health care system has supported this through the development of patient and public involvement in research. Involving patients is particularly important as their views may often differ from health care professionals and current evidence based practice, and their involvement can provide valuable insights. In addition, patient involvement provides opportunities for increased awareness of research trends, and communicating issues of importance to patients and their families in relation to their needs 1 . Moreover, patient and health care professional partnerships in research can improve the patient's health and can benefit the healthcare system generally.
In the study discussed here, the population were patients with relapsed multiple myeloma (MM). MM accounts for 2% of all cancers and is the 2 nd most common hematological malignancy 2 .
MM is a B cell malignancy resulting in uncontrolled production of plasma cells. These plasma cells overproduce immunoglobulins (heavy and light-chain M-proteins) known as a paraprotein, which build up in the bone marrow and often enter adjacent bone. The cause of MM is unknown; however it is known that the production of paraprotein in MM is associated with specific chromosomal abnormalities (deletions or translations). Almost all patients with MM will relapse, with each remission duration reducing as the number of treatment regimens increase 3 .
Patients with relapsed or refractory disease are defined as those who, having achieved minor response or better, relapse and then progress while on salvage therapy or experience progression within 60 days of their last therapy 4 .
Patients with MM are living longer resulting in its treatment as a chronic disease rather than a terminal illness. Chronic diseases are life changing and increasingly patients with MM are living with long term symptoms as a result of treatment toxicities and side effects. Symptoms have been acknowledged as a hindrance to quality of life as well as having significant effects on emotional status, activity and participation in life 5 .
In order for MM to be managed as a chronic condition patients need to be treated holistically, addressing not only their diagnosis but the symptoms and toxicities associated with treatment 6 . MM patients also need to be empowered to take control of their condition enabling them to take control of their health 7 . Evidence suggests that by helping patients to selfmanage, the risk of adverse events and hospital admissions are reduced and patients' quality of life is improved 8 .
Treatment-specific clinically focused assessment tools can be useful for optimising therapy and implementing supportive care strategies (e.g., growth factors, transfusion support, intravenous hydration, bisphosphonates, antiviral therapies) to manage treatment-related symptoms. Patient education opportunities also arise when patients are assessed resulting in a heightened awareness and encouraging prompt reporting of symptoms and side effects. When education is approached efficiently it can significantly reduce the severity of symptoms and improve overall quality of life 9 .
We report here on phase 2 (nominal group technique (NGT)) of a study aimed to develop a symptom management tool for patients with relapsed myeloma.
Methods

Ethical considerations
Ethical approval was sought and granted by the Research Ethics Committee in National University of Ireland Galway (Approval Number 16-May-05). All health care professionals agreed to partake by consenting to complete the voting card anonymously (Supplementary File 1).
Previous focus group -phase 1
We conducted four focus groups with relapsed multiple myeloma patients in various locations across Ireland (Table 1) . Some carers also attended the focus groups with their relatives. The findings of these focus groups are discussed elsewhere 10 .
At the focus groups, participants were asked to discuss their experience of common symptoms and adverse events and how these impacted on their quality of life. Patients' experience of symptom management and what improvements could be made to symptom management were also explored as well as asking patients for their opinions on a self-management tool 10 . All interviews were audio-recorded and transcribed and then analysed using thematic analysis, revealing 12 common symptoms within the patient experience.
Modified NGT -phase 2 Modified NGT was subsequently employed, with a panel of health care professionals attending a local haematology seminar. The seminar takes place every quarter and health care professionals working within the area of haematology and with experience of caring for MM patients attend. Using NGT, we wished to identify the top 5 priority symptoms to be included in a symptom management tool. Therefore participants at the seminar were asked to vote (using anonymous voting cards) in order of priority [1] [2] [3] [4] [5] , what they deemed to be of highest priority symptoms for attention in the care of patients with relapsed myeloma (Supplementary File 1).
Initially one researcher presented the findings at the haematology seminar from phase 1 of the research project "Symptom management through self-management: Improving the outcomes of patients with relapsed myeloma." This presentation included the background, progress and findings of phase 1 of the project as well as an explanation of the overall aim of the project, i.e. to develop a symptom management tool for patients. In addition the symptoms that were ranked as burdensome and explored in detail by patients were presented to the healthcare professionals (12 in total, Table 2 ).
Health care professionals consented to participate in the NGT by way of agreeing to complete the questionnaire as well as the inclusion of a consent statement, to be completed before proceeding with the voting. A total of 18 health care professionals agreed to partake in the study.
Voting cards were distributed by the 2 nd author post-presentation and participants were asked to vote anonymously on what they perceived to be the five most burdensome symptoms for patients ( Supplementary File 1) .
Modified NGT is a consensus planning tool that helps to prioritise issues 11 . This technique was devised by Delbecq and Vandeven (1971) and was chosen as the basis of our consensus as it preserved anonymity as well as fostering an exchange of opinions among multiple stakeholders in a non-threatening environment where balanced individual opinions are prioritised through a democratic method 12 . In addition, the nominal group technique allows a comparison to be made between the healthcare consumer (i.e. the patient) and healthcare professionals but also ensures patient centred healthcare. This approach has proven popular in seeking patients' involvement 13, 14 .
Results
In total, 18 health care professionals participated in the modified NGT; 6 Consultants, 2 haematology registrars, 3 specialist nurses [Advanced Nurse Practitioner/Clinical Nurse Specialist] (haematology), 1 staff nurse and 6 "other" health care professionals. Participants ranged in experience of working with myeloma patients from 2 years to greater than 27 years.
Our aim was to include the top 5 priorities for inclusion in the app; therefore the results of the voting cards were reviewed to determine which symptoms received the most votes and the ranking of the votes. Of the 12 symptoms identified by patients in the focus groups, pain was the top symptom voted by the HC professionals as essential for inclusion in a patient app. The symptom voted second was fatigue with peripheral neuropathy, infection risk and steroid induced side effects following as the symptoms that were of highest priority in the management of patients with relapsed or refractory multiple myeloma ( Table 2) . 
Discussion
This modified nominal group process provided useful information from health care professionals for the purposes of gaining consensus on what they perceived to be symptom priority for relapsed myeloma patients. Interestingly, there were similar findings between patients and health care professionals in relation to the most challenging symptoms experienced.
Fatigue and steroid induced side effects were considered two of the symptoms of highest priority for inclusion in the symptom management app. Fatigue is described in the literature as one of the most common distressing symptoms in MM. Associated causes include anaemia, pain, mood disturbance, diminished strength, diminished endurance, decreased sleep efficiency at night and advanced disease. It has also been reported that fatigue has the greatest negative effect on physical functioning in those with a diagnosis of MM. Despite this ongoing symptom burden, treatment remains episodic and self-management programmes have been limited for those on lifelong treatment 15 . Patients have already described some self-care strategies used such as resting times, distraction techniques "mind over matter", exercise and "walking off the fatigue." 10 Steroid induced side effects are often acknowledged in the development of fatigue as a long term side effect in patients with relapsed myeloma. Despite the significant impact steroids have on neuropsychiatric function and health related quality of life, it remains a useful therapy in the control of MM through improving overall patient response as well as progression free survival. Their mechanism is complex; however they are thought to modify the body's immune system and produce powerful anti-inflammatory properties. In contrast to their ability to help in the control of MM they are known to cause intense adverse effects including elevated blood sugars, increased risk of infection, mood swings and insomnia, which are often long term and not widely described or documented despite the common use of steroids 16 . Phase 1 of our study iterated these adverse events with patients describing hyperactivity, the "let down" effect and excessive diaphoresis as having a significant impact on their health related quality of life 10 . Patients were very aware of the associated side effects of steroids and reported the side effects as out of control at times. However it has been noted that patients appreciate the impact steroids can have on their disease response so they often fail to report side effects affecting their health related quality of life 10 . As such, it is of paramount importance that health care professionals educate patients and their caregivers on the importance of reporting adverse effects and thus improve patient outcomes. Education and patient involvement could improve the longer term outcomes of relapsed MM patients on steroids 10 .
The technique that we used involved a modification of the NGT. Generally there are at least 5-6 steps involved in the process; however we chose a two-step process which included two different groups of participants (patients and health care professionals). Using this technique ensured that individuals did not feel pressure to conform based on perceived status within the group, with all health care professionals voting anonymously. In addition it allowed the stakeholders to prioritise the symptoms through a democratic process 17 .
This approach has however a number of limitations. Focus group discussions with health care professionals would have provided a more comprehensive picture of symptom management for relapsed MM patients. Using just the modified NGT was a very blunt approach which provided conclusions without context. Further data would most likely have been generated if we had not modified the NGT process.
Nominal groups often request participants to record ideas independently and in private, then sharing, listing and discussing the ideas, and finally judging or voting on the ideas independently. It is usual for participants to be asked to identify issues before attending the NGT session, however in this case the issues were already identified 13 .
Conclusion
NGT offers opportunity to involve both patients and health care professionals to be involved in healthcare improvement and design. Research prioritisation now needs to focus on both patient and health care professional viewpoints to ensure a comprehensive approach to care. Patients' healthcare tools, systems and design should be used to ensure patient centred care is at the centre of healthcare reform. In addition, our study highlights that patient with chronic malignancies are willing to get involved. NGT offers potential in gaining an insight to health care professionals' priorities for patients and addressing the gap that is often described between health care professionals and patient values.
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